| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |